USANA Health Sciences Inc (USNA) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, USNA trades at $18.16 with a market cap of $333.07M and a P/E ratio of 8.25. USNA moved +4.09% today. Year to date, USNA is -4.58%; over the trailing twelve months it is -39.59%. Its 52-week range spans $16.60 to $41.84. Rallies surfaces USNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
USNA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. USNA recently traded at $18.16. Market cap is $333.07M. P/E ratio is 8.25. Revenue is $854.50M.
| Metric | Value |
|---|---|
| Price | $18.16 |
| Market Cap | $333.07M |
| P/E Ratio | 8.25 |
| EPS | $2.20 |
| Dividend Yield | 0.00% |
| 52-Week High | $41.84 |
| 52-Week Low | $16.60 |
| Volume | 31 |
| Avg Volume | 0 |
| Revenue (TTM) | $854.50M |
| Net Income | $42.06M |
| Gross Margin | 81.13% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2024 | $854.50M | $42.06M | $2.20 |
| 2023 | $921.01M | $63.79M | $3.31 |
| 2022 | $1.19B | $116.50M | $5.78 |
| 2020 | $1.13B | $124.66M | $5.89 |
USNA analyst coverage data. Average price target: $0.00.